Global and China Specialty Drug Distribution Market Size, Status and Forecast 2021-2027

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.
North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.

Market Analysis and Insights: Global Specialty Drug Distribution Market
The global Specialty Drug Distribution market size is projected to reach US$ 489820 million by 2027, from US$ 243770 million in 2020, at a CAGR of 10.6% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Specialty Drug Distribution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Specialty Drug Distribution market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Specialty Drug Distribution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Specialty Drug Distribution market.

Global Specialty Drug Distribution Scope and Market Size
Specialty Drug Distribution market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Drug Distribution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others

Segment by Application
Hospital and Clinic
Pharmacy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma